PLANTAR FASCIITIS TREATMENT MARKET SIZE TO 2026 | OTTOBOCK, RECOVER SPORTS MEDICINE, SHAPECRUNCH TECHNOLOGY PVT LTD, 3M

Global Plantar Fasciitis Treatment Market By Type (Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Others) End-User (Hospitals, Clinics, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026 Global Plantar Fasciitis Treatment Market is expected to rise to an estimated value of USD 980.40 million by 2026, registering a steady CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the high prevalence of patients suffering from plantar fasciitis globally, along with the presence of geriatric population which are more prone to suffer from this disorder.

Get Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-plantar-fasciitis-treatment-market

This Global Plantar Fasciitis Treatment Market research report is a proven and consistent source of information that gives telescopic view of the existing market trends, emerging products, situations, and opportunities that drives your business towards success. The Plantar Fasciitis Treatment Market report serves the clients to tackle every strategic aspect including product development, product specification, exploring niche growth opportunities, application modeling, and new geographical markets. Global Plantar Fasciitis Treatment Market report also provides company profiles and contact information of the key market players in the key manufacturer’s section. This Global Plantar Fasciitis Treatment Market research report is organized by collecting market research data from different corners of the globe with an experienced team of language resources.

Some of the major competitors currently working in the global plantar fasciitis treatment market are Bayer; SUPERFEET WORLDWIDE, INC.; Bauerfeind; Ottobock; Recover Sports Medicine; Shapecrunch Technology Pvt Ltd; 3M; UPMC; OrthoBethesda; APOTHECARY PRODUCTS, LLC; Ellis & Badenhausen; SYNXSOLE PTY LTD. and Revance Therapeutics, Inc. among others

Plantar fasciitis is one of the most common causes of injuries associate with the foot. It affects the heel portion of the foot and is associated with resulting of tenderness of the sole. It is a type of inflammation of the muscle of the sole. It is highly prevalent in people who stand for long periods of time on hard surfaces.

Market Drivers

Increasing availability of technically advanced product offerings and solutions for treatment of the disease; this factor is expected to fuel the growth of the market

Rising incidences of obesity is also expected to drive the growth of the market

Increasing prevalence and adoption of orthotics method of treatment prescribed by various healthcare facilities; this factor is expected to propel the growth of the market

Unique & customized product designs for each individual designed to fit in a highly accurate nature can also drive the market growth

Market Restraints

Lack of stable raw materials pricing for the production of effective therapeutic medical devices is expected to hinder the growth of the market

Concerns regarding decline of profitability ratio for the products amid availability of large inventory and raw material stock with the manufacturers is expected to restrict the market growth

Segmentation: Global Plantar Fasciitis Treatment Market

By Type

Medication Therapy

Oral

Parenteral

Orthotics

Shockwave Therapy

Extracorporeal Shock Wave Therapy (ESWT)

Intracorporeal Pneumatic Shockwave Therapy (IPST)

Surgery

Others

By End-User

Hospitals

Clinics

Others

By Geography

North America
Europe
Asia-Pacific
South America
Middle East and Africa

To Buy Complete Report Click Here  @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-plantar-fasciitis-treatment-market

Key Developments in the Market:

In January 2018, Revance Therapeutics, Inc. announced the interim Phase2a results for their neuromodulator “DaxibotulinumtoxinA for Injection” tested for the treatment of plantar fasciitis. The clinical trial’s primary endpoint showed massive reduction in pain providing pain relief to patients in comparison to placebo group. The trial also signified early and safe method of treatment with any adverse events only of a mildly severe category. The company also signified their plans to conduct a modified Phase2a trial before carrying forward to Phase2b

In February 2017, Wiivv announced that they had raised USD 4 million in Series A funding and acquisition of eSoles which will enable the company to divulge into custom-fit footwear. This expansion of the organization will enable them to undergo greater innovations and propel them to establish themselves as the leader of custom-fit footwear. This acquisition gives Wiivv a database of around 50,000 3D foot scans which can help them produce insoles with high levels of accuracy

Competitive Analysis:

Global plantar fasciitis treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of plantar fasciitis treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global plantar fasciitis treatment market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Get Full TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-plantar-fasciitis-treatment-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.